-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Orthopoxvirus
- Others
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Virus Protease
- Antiviral intermediates
Coblopasvir-dihydrochloride
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/1966138-53-3.gif)
| Category | HCV Protease |
| CAS | 1966138-53-3 |
| Description | Coblopasvir (KW-136) dihydrochloride is a pangenotypic non-structural protein 5A (NS5A) inhibitor. Coblopasvir dihydrochloride can be used for research of chronic hepatitis C virus infection. |
Product Information
| Synonyms | UNII-MW23WVJ6AD|Coblopasvir dihydrochloride|MW23WVJ6AD|1966138-53-3 |
| Molecular Weight | 855.81 |
| Molecular Formula | C41H52Cl2N8O8 |
| Purity | ≥98% (HPLC) |
| Solubility | In Vitro: DMSO : 50 mg/mL(58.42 mM;ultrasonic and warming and heat to 60°C) In Vivo: 1.Add each solvent one by one:10% DMSO >> 90% (20%SBE-β-CDin saline) Solubility: ≥ 2.5 mg/mL (2.92 mM); Clear solution 2.Add each solvent one by one:10% DMSO >> 90%corn oil Solubility: ≥ 2.5 mg/mL (2.92 mM); Clear solution |
| Appearance | White to off-white (Solid) |
| Storage | 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months -20°C, 1 month (sealed storage, away from moisture) |
| Target | HCV; HCV Protease |
